Literature DB >> 34866585

A seven-year single-center experience on AngioJet rheolytic thrombectomy in patients with pulmonary embolism at high risk and intermediate-high risk.

Özgur Yaşar Akbal1, Berhan Keskin1, Hacer Ceren Tokgöz1, Aykun Hakgör1, Ali Karagöz1, Seda Tanyeri1, Barkın Kültürsay1, Şeyhmus Külahçıoğlu1, Zübeyde Bayram1, Süleyman Efe1, Atakan Erkılınç2, İbrahim Halil Tanboğa3, Cem Doğan1, Mehmet Akbulut4, Nihal Özdemir1, Cihangir Kaymaz1.   

Abstract

BACKGROUND AND AIM: Angiojet Rheolytic thrombectomy (ART) has been utilized as a catheter-based treatment in acute pulmonary embolism (PE). In this study based on our seven-year experience on ART in patients with PE, we evaluated efficacy and safety outcomes of ART.
METHODS: Our study is based on retrospective evaluation of 56 patients with high- and intermediate-high-risk PE, age (62 years; interquartile-range (IQR): 50-73) who underwent ART.
RESULTS: High- and intermediate-high-risk were noted in 21.4 % and in 78.6 % of patients, respectively. ART duration was 304(IQR: 246-468) seconds. Measures of obstruction, right to left ventricle diameter ratio (RV/LV ratio), right to left atrial diameter ratio and pulmonary arterial pressures were improved (p<0.001 for all). During hospital stay, acute renal failure, major and minor bleeding, and mortality rates were 37.5%, 7.1%, 12.5%, and 8.9%, respectively. Aging related to post-procedural nephropathy while high-risk status was associated with in-hospital mortality (p=0.006) and long-term mortality.
CONCLUSIONS: The ART resulted in significant and clinically relevant improvements in the pulmonary arterial thrombotic burden, RV strain and hemodynamics in patients with PE at high- and intermediate-high-risk. Aging increased the risk of post-procedural nephropathy whereas baseline high-risk status predicted in-hospital and long-term mortality.

Entities:  

Mesh:

Year:  2021        PMID: 34866585      PMCID: PMC8654010          DOI: 10.5152/AnatolJCardiol.2021.28303

Source DB:  PubMed          Journal:  Anatol J Cardiol        ISSN: 2149-2263            Impact factor:   1.596


  29 in total

1.  2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.

Authors:  Stavros V Konstantinides; Adam Torbicki; Giancarlo Agnelli; Nicolas Danchin; David Fitzmaurice; Nazzareno Galiè; J Simon R Gibbs; Menno V Huisman; Marc Humbert; Nils Kucher; Irene Lang; Mareike Lankeit; John Lekakis; Christoph Maack; Eckhard Mayer; Nicolas Meneveau; Arnaud Perrier; Piotr Pruszczyk; Lars H Rasmussen; Thomas H Schindler; Pavel Svitil; Anton Vonk Noordegraaf; Jose Luis Zamorano; Maurizio Zompatori
Journal:  Eur Heart J       Date:  2014-08-29       Impact factor: 29.983

2.  Ultrasound-Assisted Catheter-Directed Thrombolysis in High-Risk and Intermediate-High-Risk Pulmonary Embolism: Results From a Single-Center Cohort.

Authors:  Cihangir Kaymaz; Selçuk Öztürk; Özgür Akbal; Ibrahim Halil Tanboğa; Fatih Yılmaz; Nertila Poçi; Sevim Türkday; Aykun Hakgör; Canan Yildiz; Tugba Aktemur; Nihal Özdemir; Stavros Konstantinides
Journal:  Angiology       Date:  2016-08-01       Impact factor: 3.619

Review 3.  Catheter-directed treatment for acute pulmonary embolism: Systematic review and single-arm meta-analyses.

Authors:  Navkaranbir S Bajaj; Rajat Kalra; Pankaj Arora; Sameer Ather; Jason L Guichard; W Jake Lancaster; Nirav Patel; Fabio Raman; Garima Arora; Firas Al Solaiman; D Trey Clark; Louis J Dell'Italia; Massoud A Leesar; James E Davies; David C McGiffin; Mustafa I Ahmed
Journal:  Int J Cardiol       Date:  2016-09-20       Impact factor: 4.164

Review 4.  Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.

Authors:  Fulvio Stacul; Aart J van der Molen; Peter Reimer; Judith A W Webb; Henrik S Thomsen; Sameh K Morcos; Torsten Almén; Peter Aspelin; Marie-France Bellin; Olivier Clement; Gertraud Heinz-Peer
Journal:  Eur Radiol       Date:  2011-08-25       Impact factor: 5.315

5.  Single-session catheter-directed lysis using adjunctive power-pulse spray with AngioJet for the treatment of acute massive and submassive pulmonary embolism.

Authors:  Laurencia Villalba; Tam Nguyen; Rui L Feitosa; Prashanth Gunanayagam; Naomi Anning; Kate Dwight
Journal:  J Vasc Surg       Date:  2019-05-27       Impact factor: 4.268

6.  Treatment of acute pulmonary embolism using rheolytic thrombectomy.

Authors:  Kun Li; Mingzhe Cui; Kewei Zhang; Kai Liang; Heng Liu; Shuiting Zhai
Journal:  EuroIntervention       Date:  2021-06-11       Impact factor: 6.534

7.  Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis.

Authors:  Saurav Chatterjee; Anasua Chakraborty; Ido Weinberg; Mitul Kadakia; Robert L Wilensky; Partha Sardar; Dharam J Kumbhani; Debabrata Mukherjee; Michael R Jaff; Jay Giri
Journal:  JAMA       Date:  2014-06-18       Impact factor: 56.272

Review 8.  Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques.

Authors:  William T Kuo; Michael K Gould; John D Louie; Jarrett K Rosenberg; Daniel Y Sze; Lawrence V Hofmann
Journal:  J Vasc Interv Radiol       Date:  2009-11       Impact factor: 3.464

9.  Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association.

Authors:  Jay Giri; Akhilesh K Sista; Ido Weinberg; Clive Kearon; Dharam J Kumbhani; Nimesh D Desai; Gregory Piazza; Mark T Gladwin; Saurav Chatterjee; Taisei Kobayashi; Christopher Kabrhel; Geoffrey D Barnes
Journal:  Circulation       Date:  2019-10-04       Impact factor: 29.690

Review 10.  Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis.

Authors:  Christophe Marti; Gregor John; Stavros Konstantinides; Christophe Combescure; Olivier Sanchez; Mareike Lankeit; Guy Meyer; Arnaud Perrier
Journal:  Eur Heart J       Date:  2014-06-10       Impact factor: 29.983

View more
  3 in total

1.  How Little Things Can Make a Big Difference?

Authors:  Evren Özçınar
Journal:  Anatol J Cardiol       Date:  2022-06       Impact factor: 1.475

2.  Reply to Letter to the Editor: "How Little Things Can Make a Big Difference?"

Authors:  Özgür Yaşar Akbal; Cihangir Kaymaz
Journal:  Anatol J Cardiol       Date:  2022-06       Impact factor: 1.475

3.  Eosinophil-to-Monocyte Ratio as a Candidate for a Novel Prognostic Marker in Acute Pulmonary Embolism: Is it a Consumptive Mechanism?

Authors:  Şeyhmus Külahçıoğlu; Hacer Ceren Tokgöz; Özgür Yaşar Akbal; Berhan Keskin; Barkın Kültürsay; Seda Tanyeri; Doğancan Çeneli; Kadir Bıyıklı; Ali Karagöz; Süleyman Çağan Efe; İbrahim Halil Tanboğa; Nihal Özdemir; Cihangir Kaymaz
Journal:  Anatol J Cardiol       Date:  2022-09       Impact factor: 1.475

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.